Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Taysha Gene Therapies, Inc. | Chief Executive Officer, Director | Common Stock | 1.54M | $2.5M | $1.63 | Jan 2, 2024 | Indirect |
Taysha Gene Therapies, Inc. | Chief Executive Officer, Director | Common Stock | 1.19M | $1.93M | $1.63 | Jan 2, 2024 | Direct |
Ventas, Inc. | Director | Common Stock | 21.3K | $1.02M | $47.96 | May 14, 2024 | Direct |
Taysha Gene Therapies, Inc. | Chief Executive Officer, Director | Employee Stock Option (right to buy) | 1.18M | Jan 2, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VTR | Ventas, Inc. | May 14, 2024 | 1 | $175K | 4 | May 16, 2024 | Director |
TSHA | Taysha Gene Therapies, Inc. | Jan 2, 2024 | 2 | $0 | 4 | Jan 4, 2024 | Chief Executive Officer, Director |
TSHA | Taysha Gene Therapies, Inc. | Dec 14, 2023 | 1 | $0 | 4 | Dec 18, 2023 | Chief Executive Officer, Director |
TSHA | Taysha Gene Therapies, Inc. | Aug 16, 2023 | 1 | $400K | 4 | Aug 16, 2023 | Chief Executive Officer, Director |
VTR | Ventas, Inc. | May 16, 2023 | 1 | $175K | 4 | May 18, 2023 | Director |
TSHA | Taysha Gene Therapies, Inc. | Dec 30, 2022 | 1 | $0 | 4 | Jan 4, 2023 | Chief Executive Officer, Director |
TSHA | Taysha Gene Therapies, Inc. | Jun 17, 2022 | 1 | $0 | 4 | Jun 22, 2022 | Director |
VTR | Ventas, Inc. | Apr 27, 2022 | 1 | $175K | 4 | Apr 29, 2022 | Director |
DNAB | Social Capital Suvretta Holdings Corp. II | Sep 24, 2021 | 0 | $0 | 3 | Sep 24, 2021 | Director |
TSHA | Taysha Gene Therapies, Inc. | Jun 17, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Director |
VTR | Ventas, Inc. | May 25, 2021 | 1 | $0 | 4 | May 27, 2021 | Director |
TSHA | Taysha Gene Therapies, Inc. | May 20, 2021 | 1 | $26.1K | 4 | May 24, 2021 | Director |